Our analysis of the G-222 GBM stem-like cell line (grown in serum-free media to maintain stem-like features) demonstrated that by comparison to the patient-matched tissue, BTK-associated activity was actually low in the cell lines (Figs 3 and 4), making it less likely to be pro-oncogenic. The gene discussed is BTK; the disease is glioblastoma.